Toll-like receptors and innate antiviral responses

Current Opinion in Immunology

Volumn 15, Issue 4, 2003, Pages 402-407

  Vaidya, Sagar A ^a   Cheng, Genhong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; INTERFERON REGULATORY FACTOR 7; RANTES; RESIQUIMOD; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CYTOKINE PRODUCTION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; NONHUMAN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VIRUS DETECTION; VIRUS INFECTION;

EID: 0041402777     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00070-0     Document Type: Review

References (46)

1. Janeway C.A. Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol. 20:2002;197-216.
2. Underhill D.M., Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol. 14:2002;103-110.
3. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol. 15:2003;5-11.
4. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 1:2001;135-145.
5. O'Neill L.A. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr Top Microbiol Immunol. 270:2002;47-61.
6. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 13:2001;85-94.
7. Aderem A. Role of Toll-like receptors in inflammatory response in macrophages. Crit Care Med. 29:2001;S16-18.
8. Sato M., Taniguchi T., Tanaka N. The interferon system and interferon regulatory factor transcription factors-studies from gene knockout mice. Cytokine Growth Factor Rev. 12:2001;133-142.
9. Taniguchi T., Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol. 14:2002;111-116.
10. Garcia-Sastre A. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microbes Infect. 4:2002;647-655.
11. Levy D.E., Marie I., Prakash A. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr Opin Immunol. 15:2003;52-58.
12. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J.et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 1:2000;398-401.
13. Haynes L.M., Moore D.D., Kurt-Jones E.A., Finberg R.W., Anderson L.J., Tripp R.A. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol. 75:2001;10730-10737.
14. Asea A., Kraeft S.K., Kurt-Jones E.A., Stevenson M.A., Chen L.B., Finberg R.W., Koo G.C., Calderwood S.K. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 6:2000;435-442.
15. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., Chow J.C., Strauss J.F. III The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem. 276:2001;10229-10233.
16. Kol A., Lichtman A.H., Finberg R.W., Libby P., Kurt-Jones E.A. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol. 164:2000;13-17.
17. Haeberle H.A., Takizawa R., Casola A., Brasier A.R., Dieterich H.J., Van Rooijen N., Gatalica Z., Garofalo R.P. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J Infect Dis. 186:2002;1199-1206.
18. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:2001;732-738.
19. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 3:2002;196-200 By generating TLR7-deficient mice, this paper demonstrates that TLR7 is required for cytokine production by the imidazoquinoline compounds imiquimod and R-848. In addition, responses to the imidazoquinolines was found to be completely MyD88-dependent.
20. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A.M., Wagner H., Lipford G., Bauer S. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol. 3:2002;499.
21. Gibson S.J., Lindh J.M., Riter T.R., Gleason R.M., Rogers L.M., Fuller A.E., Oesterich J.L., Gorden K.B., Qiu X., McKane S.W.et al. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell Immunol. 218:2002;74-86.
22. Dzionek A., Inagaki Y., Okawa K., Nagafune J., Rock J.J., Sohma Y., Winkels G., Zysk M., Yamaguchi Y., Schmitz J.J. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions(1). Hum Immunol. 63:2002;1133-1148.
23. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 168:2002;4531-4537.
24. Rassa J.C., Meyers J.L., Zhang Y., Kudaravalli R., Ross S.R. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA. 99:2002;2281-2286.
25. Bieback K., Lien E., Klagge I.M., Avota E., Schneider-Schaulies J., Duprex W.P., Wagner H., Kirschning C.J., Ter Meulen V., Schneider-Schaulies S. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol. 76:2002;8729-8736.
26. Compton T, Kurt-Jones EA, Boehme CW, Belko J, Latz E, Golenbock DT, Finberg RW: Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J Virol 2003, in press.
27. Kaisho T., Takeuchi O., Kawai T., Hoshino K., Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol. 166:2001;5688-5694.
28. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol. 167:2001;5887-5894.
29. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., Williams B.R., Major J., Hamilton T.A., Fenton M.J.et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol. 3:2002;392-398.
30. Doyle S., Vaidya S., O'Connell R., Dadgostar H., Dempsey P., Wu T., Rao G., Sun R., Haberland M., Modlin R.et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17:2002;251-263 This study identifies a subset of antiviral genes activated by stimulation with TLR3 and TLR4 ligands. IRF3 was shown to be the critical factor mediating selective upregulation of antiviral gene expression, and pre-treatment with TLR3 and TLR4 ligands could potently inhibit viral replication. The authors suggest that TLR3 and TLR4 have evolutionarily diverged from other TLRs, and are capable of activating innate antiviral responses through IRF3.
31. Arnheiter H., Skuntz S., Noteborn M., Chang S., Meier E. Transgenic mice with intracellular immunity to influenza virus. Cell. 62:1990;51-61.
32. Marie I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:1998;6660-6669.
33. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
34. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol. 2:2001;835-841.
35. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T.et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:2001;78-83.
36. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T.et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 420:2002;324-329.
37. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 420:2002;329-333.
38. Hoshino K., Kaisho T., Iwabe T., Takeuchi O., Akira S. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int Immunol. 14:2002;1225-1231.
39. ••].
40. ••] identified a novel TIR-domain containing adaptor protein (TRIF/TICAM-1) through independent approaches. Although the data are primarily based on overexpression studies, the authors make a strong case for involvement of this adaptor in the MyD88-independent pathway
41. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., O'Neill L.A. The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense. J Exp Med. 197:2003;343-351 This study demonstrates that the poxvirus has a vested interest in blocking TLR-signaling pathways, thereby implicating TLRs in the antiviral response. Infection of mice with poxvirus-mutants lacking A52R also showed a small enhancement of viral clearance in vivo.
42. Miettinen M., Sareneva T., Julkunen I., Matikainen S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2:2001;349-355.
43. Servant M.J., Grandvaux N., TenOever B.R., Duguay D., Lin R., Hiscott J. Identification of the minimal phosphoacceptor site required for in vivo activation of IRF-3 in response to virus and dsRNA. J Biol Chem. 278:2003;9441-9447.
44. Doyle S.E., O'Connell R., Vaidya S.A., Chow E.K., Yee K., Cheng G. TLR3 mediates a more potent antiviral response than TLR4. J Immunol. 170:2003;3565-3571.
45. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J: Triggering the interferon antiviral response through an IKK-related pathway. Science 2003 (published online April 17 2003) DOI: 10.1126/.1081315.
46. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 4:2003;491-496.